Toth Financial Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Hold |
230
| – | – | 0.01% | 241 |
|
|
2025
Q1 | $112K | Hold |
230
| – | – | 0.01% | 232 |
|
|
2024
Q4 | $92.6K | Sell |
230
-1,320
| -85% | -$532K | 0.01% | 245 |
|
|
2024
Q3 | $721K | Buy |
1,550
+1,450
| +1,450% | +$674K | 0.09% | 145 |
|
|
2024
Q2 | $46.9K | Hold |
100
| – | – | 0.01% | 300 |
|
|
2024
Q1 | $41.8K | Hold |
100
| – | – | 0.01% | 308 |
|
|
2023
Q4 | $40.7K | Hold |
100
| – | – | 0.01% | 314 |
|
|
2023
Q3 | $34.8K | Hold |
100
| – | – | 0.01% | 304 |
|
|
2023
Q2 | $35.2K | Sell |
100
-39
| -28% | -$13.7K | 0.01% | 312 |
|
|
2023
Q1 | $43.8K | Buy |
139
+39
| +39% | +$12.3K | 0.01% | 289 |
|
|
2022
Q4 | $28.9K | Hold |
100
| – | – | ﹤0.01% | 340 |
|
|
2022
Q3 | $29K | Hold |
100
| – | – | 0.01% | 340 |
|
|
2022
Q2 | $28K | Hold |
100
| – | – | ﹤0.01% | 334 |
|
|
2022
Q1 | $26K | Hold |
100
| – | – | ﹤0.01% | 357 |
|
|
2021
Q4 | $22K | Buy |
100
+82
| +456% | +$18K | ﹤0.01% | 394 |
|
|
2021
Q3 | $3K | Hold |
18
| – | – | ﹤0.01% | 623 |
|
|
2021
Q2 | $4K | Hold |
18
| – | – | ﹤0.01% | 522 |
|
|
2021
Q1 | $4K | Hold |
18
| – | – | ﹤0.01% | 528 |
|
|
2020
Q4 | $4K | Sell |
18
-2,875
| -99% | -$639K | ﹤0.01% | 478 |
|
|
2020
Q3 | $787K | Sell |
2,893
-1,610
| -36% | -$438K | 0.15% | 110 |
|
|
2020
Q2 | $1.31M | Buy |
4,503
+443
| +11% | +$129K | 0.28% | 83 |
|
|
2020
Q1 | $966K | Buy |
4,060
+1,330
| +49% | +$316K | 0.28% | 77 |
|
|
2019
Q4 | $598K | Buy |
+2,730
| New | +$598K | 0.12% | 113 |
|
|
2019
Q2 | – | Sell |
-1,642
| Closed | -$302K | – | 475 |
|
|
2019
Q1 | $302K | Buy |
+1,642
| New | +$302K | 0.07% | 138 |
|